Covered recipient · General Payments record
JASON C EMERSON
Allopathic & Osteopathic Physicians Orthopaedic Surgery
General Payments · PY2019–2025
$189,321.85
- Reported across 231 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Royalty or License | $3,168.76 | 3 |
| Food and Beverage | $369.53 | 11 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ENCORE MEDICAL, LP | $3,168.76 | 3 |
| MEDACTA USA, INC. | $159.86 | 2 |
| DePuy Synthes Sales Inc. | $33.79 | 2 |
| ORTHALIGN INC | $27.20 | 1 |
| Acera Surgical, Inc. | $27.16 | 1 |
| Ethicon US, LLC | $26.86 | 1 |
| PolyNovo North America LLC | $26.76 | 1 |
| Pacira Pharmaceuticals Incorporated | $25.00 | 1 |
| Anika Therapeutics, Inc. | $22.88 | 1 |
| Bioventus LLC | $20.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acera Surgical, Inc. | $27.16 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250332436 | CMS |
| Anika Therapeutics, Inc. | $22.88 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242471386 | CMS |
| Bioventus LLC | $20.02 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226853635 | CMS |
| DePuy Synthes Sales Inc. | $14.83 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174194543 | CMS |
| DePuy Synthes Sales Inc. | $18.96 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174194365 | CMS |
| ENCORE MEDICAL, LP | $1,118.49 | 02/05/2025 | Royalty or License | Undisputed | 06/30/2026 | 1255077600 | CMS |
| ENCORE MEDICAL, LP | $1,134.65 | 05/08/2025 | Royalty or License | Undisputed | 06/30/2026 | 1255077602 | CMS |
| ENCORE MEDICAL, LP | $915.62 | 08/28/2025 | Royalty or License | Undisputed | 06/30/2026 | 1255077604 | CMS |
| Ethicon US, LLC | $26.86 | 02/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1173860522 | CMS |
| Medacta USA, Inc. | $21.82 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242108965 | CMS |
| Medacta USA, Inc. | $138.04 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242108939 | CMS |
| ORTHALIGN INC | $27.20 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1193374408 | CMS |
| Pacira Pharmaceuticals Incorporated | $25.00 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250274654 | CMS |
| PolyNovo North America LLC | $26.76 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242125649 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.